The LENNY trial highlighted the system's efficacy and safety in children aged two to six years with type 1 diabetes.

Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).

Medtronic has worked with nonprofit SpineHope to give more than 200 children life-changing medical treatment since 2008 NORTHAMPTON, MA / ACCESS Newswire / July 16, 2025 / As kids go, Monica ...

Whoop pushed back on the warning letter, claiming its blood pressure feature for a wearable wristband is for “wellness” and should not be regulated as a medical device. From haphazard layoffs at the ...